Role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI)
| Main Authors: | Freeman, M., Andrianopoulos, N., Roberts, L., Brennan, A., Clark, D., Duffy, S., Ajani, A., Reid, Christopher, New, G., Teh, A. |
|---|---|
| Format: | Conference Paper |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/20.500.11937/57047 |
Similar Items
The role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation undergoing percutaneous coronary intervention
by: Parfrey, S., et al.
Published: (2021)
by: Parfrey, S., et al.
Published: (2021)
Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Batchelor, R.J., et al.
Published: (2022)
by: Batchelor, R.J., et al.
Published: (2022)
Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012)
by: Chan, W., et al.
Published: (2012)
Effect of Age on Clinical Outcomes in Elderly Patients (>80 Years) Undergoing Percutaneous Coronary Intervention : Insights From a Multi-Centre Australian PCI Registry
by: Papapostolou, S., et al.
Published: (2021)
by: Papapostolou, S., et al.
Published: (2021)
Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): A multicentre Australian registry
by: Papapostolou, S., et al.
Published: (2018)
by: Papapostolou, S., et al.
Published: (2018)
Contemporary outcomes in women undergoing percutaneous coronary intervention for acute coronary syndromes
by: Al-Fiadh, A., et al.
Published: (2011)
by: Al-Fiadh, A., et al.
Published: (2011)
Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)
by: Kuo, Chang-Fu, et al.
Published: (2016)
Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)
by: Taggar, Jaspal
Published: (2017)
Survival of Elderly Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction Complicated by Cardiogenic Shock
by: Lim, H., et al.
Published: (2009)
by: Lim, H., et al.
Published: (2009)
Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)
by: Admassie, E., et al.
Published: (2017)
TCT-250 Long-term Clinical Outcomes of Transient and Persistent No-Reflow Following Percutaneous Coronary Intervention (PCI): Insights from a Multi-center Australian Registry.
by: Papapostolou, S., et al.
Published: (2016)
by: Papapostolou, S., et al.
Published: (2016)
Clopidogrel, Prasugrel or Ticagrelor in Patients with Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention.
by: Yudi, M., et al.
Published: (2016)
by: Yudi, M., et al.
Published: (2016)
Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
by: Admassie, E., et al.
Published: (2018)
by: Admassie, E., et al.
Published: (2018)
A Study On Cyp2c19 Genetic Variations Of Clopidogrel And Ticagrelor Treatment Among Coronary Artery Disease (CAD) Patients Undergoing Percutaneous Coronary Intervention (PCI)
by: Ak-Kaif, Mohammed Ahmed Imran
Published: (2023)
by: Ak-Kaif, Mohammed Ahmed Imran
Published: (2023)
TemporalTrends of Heart Failure Patients Undergoing Percutaneous Coronary Intervention: Findings From Melbourne Interventional Group Registry
by: Chin, K., et al.
Published: (2017)
by: Chin, K., et al.
Published: (2017)
Stroke prevention in atrial fibrillation: An update on current management strategies
by: Hall, Toby, et al.
Published: (2013)
by: Hall, Toby, et al.
Published: (2013)
Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: The Atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2012)
by: Huxley, Rachel, et al.
Published: (2012)
Australian Trends in Procedural Characteristics and Outcomes in Patients Undergoing Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction
by: Biswas, S., et al.
Published: (2017)
by: Biswas, S., et al.
Published: (2017)
Impact of concomitant heart failure on outcomes in patients undergoing percutaneous coronary interventions: Analysis of the Melbourne Interventional Group registry
by: Lu, K., et al.
Published: (2011)
by: Lu, K., et al.
Published: (2011)
The impact of percutaneous coronary intervention (PCI) on diastolic dysfunction in coronary artery disease
by: Umar, Bello Tambuwal
Published: (2014)
by: Umar, Bello Tambuwal
Published: (2014)
Does Preoperative Atrial Fibrillation Portend a Poorer Prognosis in Patients Undergoing Isolated Aortic Valve Replacement? A Multicentre Australian Study
by: Saxena, A., et al.
Published: (2013)
by: Saxena, A., et al.
Published: (2013)
Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation
by: Huxley, Rachel, et al.
Published: (2011)
by: Huxley, Rachel, et al.
Published: (2011)
ENVIRONMENTAL SUSTAINABILITY APPRAISAL OF THE ATRIAL FIBRILLATION CARE PATHWAY
by: Munawar, Sana
Published: (2016)
by: Munawar, Sana
Published: (2016)
Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018)
by: Obamiro, K., et al.
Published: (2018)
Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018)
by: Obamiro, K., et al.
Published: (2018)
Does Statin Benefits Patients with Heart Failure Undergoing Percutaneous Coronary Intervention? Findings from the Melbourne Interventional Group Registry
by: Chin, K., et al.
Published: (2018)
by: Chin, K., et al.
Published: (2018)
Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings from Melbourne Interventional Group Registry
by: Chin, K., et al.
Published: (2018)
by: Chin, K., et al.
Published: (2018)
Survival in patients with myocardial infarction complicated by out-of-hospital cardiac arrest undergoing emergency percutaneous coronary intervention
by: Lim, H., et al.
Published: (2013)
by: Lim, H., et al.
Published: (2013)
Screening for atrial fibrillation in primary care: from recommendation to implementation
by: Taggar, Jaspal, et al.
Published: (2016)
by: Taggar, Jaspal, et al.
Published: (2016)
Bleeding Severity in Percutaneous Coronary Intervention (PCI) and Its Impact on Short-Term Clinical Outcomes
by: Murali, Shashank, et al.
Published: (2020)
by: Murali, Shashank, et al.
Published: (2020)
The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients
by: Russell, E., et al.
Published: (2017)
by: Russell, E., et al.
Published: (2017)
Knowledge of atrial fibrillation and stroke prevention: development of questionnaire and validation of results
by: Mohamed, Sahimi, et al.
Published: (2017)
by: Mohamed, Sahimi, et al.
Published: (2017)
Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)
by: Admassie, E., et al.
Published: (2017)
Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016)
by: Bista, D., et al.
Published: (2016)
Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
by: Bista, D., et al.
Published: (2017)
by: Bista, D., et al.
Published: (2017)
Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results
by: Sahimi, Mohamed, et al.
Published: (2016)
by: Sahimi, Mohamed, et al.
Published: (2016)
Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)
Postoperative atrial fibrillation after isolated aortic valve replacement: A cause for concern?
by: Saxena, A., et al.
Published: (2013)
by: Saxena, A., et al.
Published: (2013)
Pretreatment with Dual Antiplatelet Therapy in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes undergoing Percutaneous Coronary Intervention
by: Yudi, M., et al.
Published: (2015)
by: Yudi, M., et al.
Published: (2015)
Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry
by: Fernando, H., et al.
Published: (2021)
by: Fernando, H., et al.
Published: (2021)
Similar Items
-
The role of CHA2DS2-VASc score in evaluating patients with atrial fibrillation undergoing percutaneous coronary intervention
by: Parfrey, S., et al.
Published: (2021) -
Adverse 30-Day Clinical Outcomes and Long-Term Mortality Among Patients With Preprocedural Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: Batchelor, R.J., et al.
Published: (2022) -
Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention
by: Chan, W., et al.
Published: (2012) -
Effect of Age on Clinical Outcomes in Elderly Patients (>80 Years) Undergoing Percutaneous Coronary Intervention : Insights From a Multi-Centre Australian PCI Registry
by: Papapostolou, S., et al.
Published: (2021) -
Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): A multicentre Australian registry
by: Papapostolou, S., et al.
Published: (2018)